Clinical Trial Update: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing inhaled tissue plasminogen activator for acute plastic bronchitis. Results were posted on 2023-11-01.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plastic Bronchitis
• Protein-losing Enteropathy

Drugs mentioned

• Alteplase (tissue plasminogen activator) (alteplase)

Snippet

Sponsor: University of Michigan | Conditions: Plastic Bronchitis, Protein-Losing Enteropathies | Phase 2 | Status: COMPLETED | Results posted: 2023-11-01